glp 1 approved for pediatrics GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025 GLP-1s and Kids: What Parents

Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis

half-life Not well established in humans Practical effect window Hours per dose

Prices range from $250 for a 250ml infusion to $325 for a 1000ml infusion

Augmenting brain B 12 with fingolimod or potentially related molecules could enhance both current and future MS therapies. In their paper, the team at Sanford Burnham Prebys, with collaborators at University of Southern California, Juntendo University in Japan, Tokyo University of Pharmacy and Life Sciences and State University of New York, focused on the molecular functioning of FTY720 or fingolimod (Gilenya), a sphingosine 1-phosphate (S1P) receptor modulator that suppresses distribution of T and B immune cells errantly attacking the brains of MS patients

Casey, T., Bond, J., Tighe, S., Hunter, T., Lintault, L., Patel, O., et al